Recurrent emergence of SARS-CoV-2 spike deletion H69/V70 and its role in the Alpha variant B.1.1.7.
Saved in:
| Title: | Recurrent emergence of SARS-CoV-2 spike deletion H69/V70 and its role in the Alpha variant B.1.1.7. |
|---|---|
| Authors: | Meng B; Cambridge Institute of Therapeutic Immunology & Infectious Disease (CITIID), Cambridge, UK; Department of Medicine, University of Cambridge, Cambridge, UK., Kemp SA; Cambridge Institute of Therapeutic Immunology & Infectious Disease (CITIID), Cambridge, UK; Department of Medicine, University of Cambridge, Cambridge, UK; Division of Infection and Immunity, University College London, London, UK., Papa G; MRC - Laboratory of Molecular Biology, Cambridge, UK., Datir R; Cambridge Institute of Therapeutic Immunology & Infectious Disease (CITIID), Cambridge, UK; Department of Medicine, University of Cambridge, Cambridge, UK., Ferreira IATM; Cambridge Institute of Therapeutic Immunology & Infectious Disease (CITIID), Cambridge, UK; Department of Medicine, University of Cambridge, Cambridge, UK., Marelli S; Cambridge Institute of Therapeutic Immunology & Infectious Disease (CITIID), Cambridge, UK; Department of Medicine, University of Cambridge, Cambridge, UK., Harvey WT; Institute of Biodiversity, Animal Health and Comparative Medicine, University of Glasgow, Glasgow, UK; MRC - University of Glasgow Centre for Virus Research, Glasgow, UK., Lytras S; MRC - University of Glasgow Centre for Virus Research, Glasgow, UK., Mohamed A; Pirbright Institute, Woking, Surrey, UK., Gallo G; Pirbright Institute, Woking, Surrey, UK., Thakur N; Pirbright Institute, Woking, Surrey, UK., Collier DA; Cambridge Institute of Therapeutic Immunology & Infectious Disease (CITIID), Cambridge, UK; Department of Medicine, University of Cambridge, Cambridge, UK; Division of Infection and Immunity, University College London, London, UK., Mlcochova P; Cambridge Institute of Therapeutic Immunology & Infectious Disease (CITIID), Cambridge, UK; Department of Medicine, University of Cambridge, Cambridge, UK., Duncan LM; Cambridge Institute of Therapeutic Immunology & Infectious Disease (CITIID), Cambridge, UK; Department of Medicine, University of Cambridge, Cambridge, UK., Carabelli AM; Department of Medicine, University of Cambridge, Cambridge, UK., Kenyon JC; Department of Medicine, University of Cambridge, Cambridge, UK; Department of Microbiology and Immunology, Yong Loo Lin School of Medicine, National University of Singapore, Singapore, Singapore., Lever AM; Department of Medicine, University of Cambridge, Cambridge, UK; Department of Medicine, Yong Loo Lin School of Medicine, National University of Singapore, Singapore, Singapore., De Marco A; Humabs Biomed SA, a subsidiary of Vir Biotechnology, 6500 Bellinzona, Switzerland., Saliba C; Humabs Biomed SA, a subsidiary of Vir Biotechnology, 6500 Bellinzona, Switzerland., Culap K; Humabs Biomed SA, a subsidiary of Vir Biotechnology, 6500 Bellinzona, Switzerland., Cameroni E; Humabs Biomed SA, a subsidiary of Vir Biotechnology, 6500 Bellinzona, Switzerland., Matheson NJ; Cambridge Institute of Therapeutic Immunology & Infectious Disease (CITIID), Cambridge, UK; Department of Medicine, University of Cambridge, Cambridge, UK; NHS Blood and Transplant, Cambridge, UK., Piccoli L; Humabs Biomed SA, a subsidiary of Vir Biotechnology, 6500 Bellinzona, Switzerland., Corti D; Humabs Biomed SA, a subsidiary of Vir Biotechnology, 6500 Bellinzona, Switzerland., James LC; MRC - Laboratory of Molecular Biology, Cambridge, UK., Robertson DL; MRC - University of Glasgow Centre for Virus Research, Glasgow, UK., Bailey D; Pirbright Institute, Woking, Surrey, UK. Electronic address: dalan.bailey@pirbright.ac.uk., Gupta RK; Cambridge Institute of Therapeutic Immunology & Infectious Disease (CITIID), Cambridge, UK; Department of Medicine, University of Cambridge, Cambridge, UK; Africa Health Research Institute, Durban, South Africa. Electronic address: rkg20@cam.ac.uk. |
| Corporate Authors: | COVID-19 Genomics UK (COG-UK) Consortium; https://www.cogconsortium.uk. |
| Source: | Cell reports [Cell Rep] 2021 Jun 29; Vol. 35 (13), pp. 109292. Date of Electronic Publication: 2021 Jun 08. |
| Publication Type: | Journal Article; Research Support, Non-U.S. Gov't |
| Journal Info: | Publisher: Cell Press Country of Publication: United States NLM ID: 101573691 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2211-1247 (Electronic) NLM ISO Abbreviation: Cell Rep Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
| FullText | Text: Availability: 0 |
|---|---|
| Header | DbId: mdl DbLabel: MEDLINE Ultimate An: 34166617 AccessLevel: 2 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: Recurrent emergence of SARS-CoV-2 spike deletion H69/V70 and its role in the Alpha variant B.1.1.7. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AU" term="%22Meng+B%22">Meng B</searchLink>; Cambridge Institute of Therapeutic Immunology & Infectious Disease (CITIID), Cambridge, UK; Department of Medicine, University of Cambridge, Cambridge, UK.<br /><searchLink fieldCode="AU" term="%22Kemp+SA%22">Kemp SA</searchLink>; Cambridge Institute of Therapeutic Immunology & Infectious Disease (CITIID), Cambridge, UK; Department of Medicine, University of Cambridge, Cambridge, UK; Division of Infection and Immunity, University College London, London, UK.<br /><searchLink fieldCode="AU" term="%22Papa+G%22">Papa G</searchLink>; MRC - Laboratory of Molecular Biology, Cambridge, UK.<br /><searchLink fieldCode="AU" term="%22Datir+R%22">Datir R</searchLink>; Cambridge Institute of Therapeutic Immunology & Infectious Disease (CITIID), Cambridge, UK; Department of Medicine, University of Cambridge, Cambridge, UK.<br /><searchLink fieldCode="AU" term="%22Ferreira+IATM%22">Ferreira IATM</searchLink>; Cambridge Institute of Therapeutic Immunology & Infectious Disease (CITIID), Cambridge, UK; Department of Medicine, University of Cambridge, Cambridge, UK.<br /><searchLink fieldCode="AU" term="%22Marelli+S%22">Marelli S</searchLink>; Cambridge Institute of Therapeutic Immunology & Infectious Disease (CITIID), Cambridge, UK; Department of Medicine, University of Cambridge, Cambridge, UK.<br /><searchLink fieldCode="AU" term="%22Harvey+WT%22">Harvey WT</searchLink>; Institute of Biodiversity, Animal Health and Comparative Medicine, University of Glasgow, Glasgow, UK; MRC - University of Glasgow Centre for Virus Research, Glasgow, UK.<br /><searchLink fieldCode="AU" term="%22Lytras+S%22">Lytras S</searchLink>; MRC - University of Glasgow Centre for Virus Research, Glasgow, UK.<br /><searchLink fieldCode="AU" term="%22Mohamed+A%22">Mohamed A</searchLink>; Pirbright Institute, Woking, Surrey, UK.<br /><searchLink fieldCode="AU" term="%22Gallo+G%22">Gallo G</searchLink>; Pirbright Institute, Woking, Surrey, UK.<br /><searchLink fieldCode="AU" term="%22Thakur+N%22">Thakur N</searchLink>; Pirbright Institute, Woking, Surrey, UK.<br /><searchLink fieldCode="AU" term="%22Collier+DA%22">Collier DA</searchLink>; Cambridge Institute of Therapeutic Immunology & Infectious Disease (CITIID), Cambridge, UK; Department of Medicine, University of Cambridge, Cambridge, UK; Division of Infection and Immunity, University College London, London, UK.<br /><searchLink fieldCode="AU" term="%22Mlcochova+P%22">Mlcochova P</searchLink>; Cambridge Institute of Therapeutic Immunology & Infectious Disease (CITIID), Cambridge, UK; Department of Medicine, University of Cambridge, Cambridge, UK.<br /><searchLink fieldCode="AU" term="%22Duncan+LM%22">Duncan LM</searchLink>; Cambridge Institute of Therapeutic Immunology & Infectious Disease (CITIID), Cambridge, UK; Department of Medicine, University of Cambridge, Cambridge, UK.<br /><searchLink fieldCode="AU" term="%22Carabelli+AM%22">Carabelli AM</searchLink>; Department of Medicine, University of Cambridge, Cambridge, UK.<br /><searchLink fieldCode="AU" term="%22Kenyon+JC%22">Kenyon JC</searchLink>; Department of Medicine, University of Cambridge, Cambridge, UK; Department of Microbiology and Immunology, Yong Loo Lin School of Medicine, National University of Singapore, Singapore, Singapore.<br /><searchLink fieldCode="AU" term="%22Lever+AM%22">Lever AM</searchLink>; Department of Medicine, University of Cambridge, Cambridge, UK; Department of Medicine, Yong Loo Lin School of Medicine, National University of Singapore, Singapore, Singapore.<br /><searchLink fieldCode="AU" term="%22De+Marco+A%22">De Marco A</searchLink>; Humabs Biomed SA, a subsidiary of Vir Biotechnology, 6500 Bellinzona, Switzerland.<br /><searchLink fieldCode="AU" term="%22Saliba+C%22">Saliba C</searchLink>; Humabs Biomed SA, a subsidiary of Vir Biotechnology, 6500 Bellinzona, Switzerland.<br /><searchLink fieldCode="AU" term="%22Culap+K%22">Culap K</searchLink>; Humabs Biomed SA, a subsidiary of Vir Biotechnology, 6500 Bellinzona, Switzerland.<br /><searchLink fieldCode="AU" term="%22Cameroni+E%22">Cameroni E</searchLink>; Humabs Biomed SA, a subsidiary of Vir Biotechnology, 6500 Bellinzona, Switzerland.<br /><searchLink fieldCode="AU" term="%22Matheson+NJ%22">Matheson NJ</searchLink>; Cambridge Institute of Therapeutic Immunology & Infectious Disease (CITIID), Cambridge, UK; Department of Medicine, University of Cambridge, Cambridge, UK; NHS Blood and Transplant, Cambridge, UK.<br /><searchLink fieldCode="AU" term="%22Piccoli+L%22">Piccoli L</searchLink>; Humabs Biomed SA, a subsidiary of Vir Biotechnology, 6500 Bellinzona, Switzerland.<br /><searchLink fieldCode="AU" term="%22Corti+D%22">Corti D</searchLink>; Humabs Biomed SA, a subsidiary of Vir Biotechnology, 6500 Bellinzona, Switzerland.<br /><searchLink fieldCode="AU" term="%22James+LC%22">James LC</searchLink>; MRC - Laboratory of Molecular Biology, Cambridge, UK.<br /><searchLink fieldCode="AU" term="%22Robertson+DL%22">Robertson DL</searchLink>; MRC - University of Glasgow Centre for Virus Research, Glasgow, UK.<br /><searchLink fieldCode="AU" term="%22Bailey+D%22">Bailey D</searchLink>; Pirbright Institute, Woking, Surrey, UK. Electronic address: dalan.bailey@pirbright.ac.uk.<br /><searchLink fieldCode="AU" term="%22Gupta+RK%22">Gupta RK</searchLink>; Cambridge Institute of Therapeutic Immunology & Infectious Disease (CITIID), Cambridge, UK; Department of Medicine, University of Cambridge, Cambridge, UK; Africa Health Research Institute, Durban, South Africa. Electronic address: rkg20@cam.ac.uk. – Name: AuthorCorporate Label: Corporate Authors Group: Au Data: <searchLink fieldCode="CA" term="%22COVID-19+Genomics+UK+%28COG-UK%29+Consortium%22">COVID-19 Genomics UK (COG-UK) Consortium</searchLink>; https://www.cogconsortium.uk. – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%22101573691%22">Cell reports</searchLink> [Cell Rep] 2021 Jun 29; Vol. 35 (13), pp. 109292. <i>Date of Electronic Publication: </i>2021 Jun 08. – Name: TypePub Label: Publication Type Group: TypPub Data: Journal Article; Research Support, Non-U.S. Gov't – Name: TitleSource Label: Journal Info Group: Src Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Cell+Press%22">Cell Press </searchLink><i>Country of Publication: </i>United States <i>NLM ID: </i>101573691 <i>Publication Model: </i>Print-Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>2211-1247 (Electronic) <i>NLM ISO Abbreviation: </i>Cell Rep <i>Subsets: </i>MEDLINE |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=34166617 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.1016/j.celrep.2021.109292 Languages: – Code: eng Text: English PhysicalDescription: Pagination: StartPage: 109292 Titles: – TitleFull: Recurrent emergence of SARS-CoV-2 spike deletion H69/V70 and its role in the Alpha variant B.1.1.7. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Meng B – PersonEntity: Name: NameFull: Kemp SA – PersonEntity: Name: NameFull: Papa G – PersonEntity: Name: NameFull: Datir R – PersonEntity: Name: NameFull: Ferreira IATM – PersonEntity: Name: NameFull: Marelli S – PersonEntity: Name: NameFull: Harvey WT – PersonEntity: Name: NameFull: Lytras S – PersonEntity: Name: NameFull: Mohamed A – PersonEntity: Name: NameFull: Gallo G – PersonEntity: Name: NameFull: Thakur N – PersonEntity: Name: NameFull: Collier DA – PersonEntity: Name: NameFull: Mlcochova P – PersonEntity: Name: NameFull: Duncan LM – PersonEntity: Name: NameFull: Carabelli AM – PersonEntity: Name: NameFull: Kenyon JC – PersonEntity: Name: NameFull: Lever AM – PersonEntity: Name: NameFull: De Marco A – PersonEntity: Name: NameFull: Saliba C – PersonEntity: Name: NameFull: Culap K – PersonEntity: Name: NameFull: Cameroni E – PersonEntity: Name: NameFull: Matheson NJ – PersonEntity: Name: NameFull: Piccoli L – PersonEntity: Name: NameFull: Corti D – PersonEntity: Name: NameFull: James LC – PersonEntity: Name: NameFull: Robertson DL – PersonEntity: Name: NameFull: Bailey D – PersonEntity: Name: NameFull: Gupta RK IsPartOfRelationships: – BibEntity: Dates: – D: 29 M: 06 Text: 2021 Jun 29 Type: published Y: 2021 Identifiers: – Type: issn-electronic Value: 2211-1247 Numbering: – Type: volume Value: 35 – Type: issue Value: 13 Titles: – TitleFull: Cell reports Type: main |
| ResultId | 1 |